Are you from Oregon? You may be losing a very important tool to help you survive cancer. Please stand up to keep providing Medicaid coverage of FDA approved comprehensive genomic sequencing. Many lives depend on it!
OREGON CALL TO ACTION!
The state of Oregon Health Authority Health Evidence Review Commission (HERC) recently released proposed guidance to not provide coverage for the use of FDA-Approved Next Generation Sequencing (NGS) tests for cancer patients in the state with Medicaid.
LUNGevity Foundation and Caring Ambassadors are seeking volunteers–both lung cancer survivors and health care professionals–who live in the state of Oregon, to provide testimony at a public meeting on this issue scheduled for 1:00pm-4:00pm on September 27, 2018 in Wilsonville, Oregon. Ideal testimony would be provided by survivors who have received NGS, or other comprehensive biomarker testing, to guide their treatment and by health care professionals who order, consult, or care for patients who have received NGS, or other comprehensive biomarker testing.For more information or to volunteer, please contact:
- Anna Pugh, LUNGevity Foundation Director of Public Policy Initiatives, at firstname.lastname@example.org or 240-454-3105 or
- Cindy Langhorne, Caring Ambassadors Lung Cancer Program Director at email@example.com or 503-632-9032 ext. 1.
A copy of the comments submitted by LUNGevity Foundation to the HERC can be found here.
Thanks to Matt Ellefson at SURVIVEiT! for helping to make this need known.